Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PF-06651600 on Rosuvastatin PK in Healthy Participants
NCT04092595Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ritlecitinib tosilate in alopecia areata, sponsored by Pfizer. Primary endpoints: Area Under the Curve From Time Zero to Extrapolated Infinite Time at Day 8 and Renal Clearance at Day 8. Started Sep 2019; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04092595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092595.